Molecular Diversity of Lupane Hybrids in Drug Design and Materials Science

dc.authoridhttps://orcid.org/0000-0003-0922-1785
dc.authoridhttps://orcid.org/0000-0002-1707-5397
dc.authoridhttps://orcid.org/0000-0001-6373-5221
dc.authoridhttps://orcid.org/0000-0001-7982-6988
dc.authoridhttps://orcid.org/0000-0001-7564-778X
dc.contributor.authorLipson, Victoria V.
dc.contributor.authorShirobokova, Maria G.
dc.contributor.authorGümüş, Mustafa Kemal
dc.contributor.authorÖztürkcan, Arda
dc.contributor.authorChebanov, Valentyn A.
dc.date.accessioned2025-11-06T09:19:10Z
dc.date.issued2025
dc.departmentSağlık Bilimleri Fakültesi
dc.description.abstractThe need for new, more effective drugs to treat cancer, infectious diseases, various parasitic infestations, and metabolic disorders requires innovative approaches to the design of promising molecules. One of these areas is the creation of hybrid structures. Lupane triterpenoids are of significant interest for such research due to their high abundance in natural sources and their renewable nature, their molecular architecture, presence of several easily modifiable functional groups, enantiomeric purity, broad spectrum of biological activity, and low toxicity. Active research into the biological properties of new pentacyclic triterpenoid derivatives, not only of the lupane series but also of the oleonane and ursane series, is evidenced by the large number of reviews and experimental studies devoted to this topic. Our interest in the modification of lupanoids stems not only from the search for biologically active compounds but also from the development of functional materials. However, the materials science aspects of lupanoid applications are virtually unknown in literature. We have tried to fill this gap and examined the possibility of using betulin derivatives to create advanced materials. The high lipophilicity and nanoscale molecular structure of these compounds make them highly promising as chiral dopants in liquid crystal compositions and organogel components.
dc.identifier.citationLipson, V.V.; Shirobokova, M.G.; Gümü¸s, M.K.; Ozturkcan, A.; Chebanov, V.A. Molecular Diversity of Lupane Hybrids in Drug Design and Materials Science. Molecules 2025, 30, 4108. https://doi.org/10.3390/molecules30204108
dc.identifier.doihttps://doi.org/10.3390/molecules30204108
dc.identifier.issn1420-3049
dc.identifier.issue20
dc.identifier.urihttps://hdl.handle.net/11363/10571
dc.identifier.volume30
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.institutionauthorÖztürkcan, Arda
dc.institutionauthoridhttps://orcid.org/0000-0001-7982-6988
dc.language.isoen
dc.publisherMDPI, MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
dc.relation.ispartofMOLECULES
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectlupane triterpenoids
dc.subjectbetulinic acid
dc.subjectbiological activity
dc.subjectliquid crystals
dc.subjectchiral dopants
dc.subjectorganogels
dc.titleMolecular Diversity of Lupane Hybrids in Drug Design and Materials Science
dc.typeReview Article

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Makale / Article
Boyut:
4.64 MB
Biçim:
Adobe Portable Document Format

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: